Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

In a new study published in Cell Reports, researchers at the University of Freiburg reveal how a disordered protein segment ...

The majority of RNAs in each of our cells don't code for any of the thousands of proteins that make up our bodies. Instead, ...

Eli Lilly is further expanding its RNA medicine strategy by tapping South Korea’s Rznomics for a $1.3 billion biobucks deal ...

Lilly will use Rznomics’ proprietary ribozyme technology to develop RNA editing therapies for congenital hearing loss.

The RNP complex is the influenza virus’s essential package, the virus’s blueprints and a copy machine all rolled in one. The ...

The siRNA technology has has the potential to enable sustained and precise messenger RNA silencing, regulating the expression ...

Our premium News+ ad-free experience – only $10 more every 4 weeks!

Eli Lilly signs a global licensing deal with Rznomics to co-develop RNA-editing therapies for hearing loss, with potential ...

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

Dr. Anastasia Khvorova for her pioneering work in the field of RNA-based therapies. At 2.5 million euros, the prize is one of the most prestigious and generously endowed of any medical research prize ...